Safety And Efficacy Of Eculizumab Therapy In Adult Patients With Transplant-Associated Thrombotic Microangiopathy (TA-TMA).
Phase of Trial: Phase IV
Latest Information Update: 21 Jan 2017
At a glance
- Drugs Eculizumab (Primary)
- Indications Thrombotic microangiopathy
- Focus Adverse reactions; Therapeutic Use
- 21 Jan 2017 New trial record
- 06 Dec 2016 Results presented at the 58th Annual Meeting and Exposition of the American Society of Hematology.